Cite
Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity
MLA
Chia Yee Tan, et al. “Systematic in Vivo Candidate Evaluation Uncovers Therapeutic Targets for LMNA Dilated Cardiomyopathy and Risk of Lamin A Toxicity.” Journal of Translational Medicine, vol. 21, no. 1, Oct. 2023, pp. 1–20. EBSCOhost, https://doi.org/10.1186/s12967-023-04542-4.
APA
Chia Yee Tan, Pui Shi Chan, Hansen Tan, Sung Wei Tan, Chang Jie Mick Lee, Jiong-Wei Wang, Shu Ye, Hendrikje Werner, Ying Jie Loh, Yin Loon Lee, Matthew Ackers-Johnson, Roger S. Y. Foo, & Jianming Jiang. (2023). Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity. Journal of Translational Medicine, 21(1), 1–20. https://doi.org/10.1186/s12967-023-04542-4
Chicago
Chia Yee Tan, Pui Shi Chan, Hansen Tan, Sung Wei Tan, Chang Jie Mick Lee, Jiong-Wei Wang, Shu Ye, et al. 2023. “Systematic in Vivo Candidate Evaluation Uncovers Therapeutic Targets for LMNA Dilated Cardiomyopathy and Risk of Lamin A Toxicity.” Journal of Translational Medicine 21 (1): 1–20. doi:10.1186/s12967-023-04542-4.